| 1 | = | Malignant Colon Neoplasm | +2.72 | 100 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 40801
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.074626
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.011322
- activeTrials
- 225
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9322
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580336 |
| 2 | = | Malignant Gallbladder Neoplasm | +2.32 | 97.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4402
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.008051
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.00161
- activeTrials
- 32
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9574
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580337 |
| 3 | = | Cutaneous Melanoma | +2.01 | 94.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 8671
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.01586
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.003925
- activeTrials
- 78
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9826
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580338 |
| 4 | = | Malignant Laryngeal Neoplasm | +1.17 | 91.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4095
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.00749
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.003321
- activeTrials
- 66
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9700
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580339 |
| 5 | = | Malignant Pancreatic Neoplasm | +1.05 | 88.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 51327
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.093879
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.045491
- activeTrials
- 904
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9637
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580340 |
| 6 | = | Malignant Bladder Neoplasm | +0.87 | 85.3 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 17396
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.031818
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.017411
- activeTrials
- 346
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10702
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580341 |
| 7 | = | Malignant Lung Neoplasm | +0.82 | 82.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 128762
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.23551
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.133052
- activeTrials
- 2644
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9763
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580342 |
| 8 | = | Skin Carcinoma | +0.64 | 79.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 5462
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.00999
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.006391
- activeTrials
- 127
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9889
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580343 |
| 9 | = | Malignant Lip and Oral Cavity Neoplasm | +0.4 | 76.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 5424
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.009921
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.007498
- activeTrials
- 149
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 8881
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580344 |
| 10 | = | Malignant Rectal Neoplasm | +0.34 | 73.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 13446
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.024593
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.019424
- activeTrials
- 386
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9385
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580345 |
| 11 | = | Malignant Liver Neoplasm | +0.29 | 70.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 30532
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.055844
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.045592
- activeTrials
- 906
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9511
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580346 |
| 12 | = | Malignant Kidney Neoplasm | +0.29 | 67.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 15215
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.027829
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.022796
- activeTrials
- 453
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10639
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580347 |
| 13 | = | Malignant Esophageal Neoplasm | +0.19 | 64.7 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 16274
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.029766
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.026067
- activeTrials
- 518
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9196
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580348 |
| 14 | = | Malignant Vulvar Neoplasm | +0.07 | 61.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1555
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.002844
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.002717
- activeTrials
- 54
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10135
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580349 |
| 15 | = | Malignant Prostate Neoplasm | -0.12 | 58.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 34815
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.063678
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.069193
- activeTrials
- 1375
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10513
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580350 |
| 16 | = | Malignant Anal Neoplasm | -0.18 | 55.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1651
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.00302
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.003422
- activeTrials
- 68
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9448
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580351 |
| 17 | = | Malignant Oropharyngeal Neoplasm | -0.26 | 52.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 3286
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.00601
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.007196
- activeTrials
- 143
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9007
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580352 |
| 18 | = | Malignant Central Nervous System Neoplasm | -0.29 | 50 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 18523
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.033879
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.041415
- activeTrials
- 823
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10765
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580353 |
| 19 | = | Malignant Mesothelioma | -0.32 | 47.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 2114
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.003867
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.004831
- activeTrials
- 96
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9952
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580354 |
| 20 | = | Malignant Uterine Corpus Neoplasm | -0.39 | 44.1 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 8608
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.015744
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.020682
- activeTrials
- 411
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10324
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580355 |
| 21 | = | Malignant Salivary Gland Neoplasm | -0.56 | 41.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 1173
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.002145
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.00317
- activeTrials
- 63
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 8944
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580356 |
| 22 | = | Malignant Ovarian Neoplasm | -0.57 | 38.2 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 12654
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.023145
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.03442
- activeTrials
- 684
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10387
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580357 |
| 23 | = | Malignant Gastric Neoplasm | -0.67 | 35.3 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 11246
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.020569
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.03281
- activeTrials
- 652
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9259
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580358 |
| 24 | = | Malignant Breast Neoplasm | -0.72 | 32.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 43897
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.080289
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.132196
- activeTrials
- 2627
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10072
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580359 |
| 25 | = | Multiple Myeloma | -0.9 | 29.4 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 11967
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.021888
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.040962
- activeTrials
- 814
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 11017
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580360 |
| 26 | = | Malignant Vaginal Neoplasm | -0.97 | 26.5 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 435
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.000796
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.00156
- activeTrials
- 31
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10198
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580361 |
| 27 | = | Leukemia | -1.04 | 23.5 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 23740
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.043421
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.08902
- activeTrials
- 1769
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 11080
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580362 |
| 28 | = | Malignant Thyroid Gland Neoplasm | -1.12 | 20.6 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 2229
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.004077
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.008857
- activeTrials
- 176
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10828
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580363 |
| 29 | = | Malignant Testicular Neoplasm | -1.36 | 17.6 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 462
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.000845
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.002164
- activeTrials
- 43
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10576
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580364 |
| 30 | = | Malignant Penile Neoplasm | -1.51 | 14.7 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 415
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.000759
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.002164
- activeTrials
- 43
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10450
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580365 |
| 31 | = | Malignant Hypopharyngeal Neoplasm | -1.55 | 11.8 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 498
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.000911
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.002667
- activeTrials
- 53
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9133
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580366 |
| 32 | = | Non-Hodgkin Lymphoma | -1.59 | 8.8 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 19882
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.036365
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.109098
- activeTrials
- 2168
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10954
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580367 |
| 33 | = | Malignant Cervical Neoplasm | -1.72 | 5.9 | High confidence | cdc-wonderclinicaltrials | inputs- deaths
- 4207
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.007695
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.025413
- activeTrials
- 505
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10261
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580368 |
| 34 | = | Hodgkin Lymphoma | -2.44 | 2.9 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 909
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.001663
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.009008
- activeTrials
- 179
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 10891
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580369 |
| 35 | = | Malignant Nasopharyngeal Neoplasm | -3.43 | 0 | Medium confidence | cdc-wonderclinicaltrials | inputs- deaths
- 664
- formula
- log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
- sumDeaths
- 546737
- deathShare
- 0.001214
- thresholds
- minDeaths
- 100
- minActivity
- 1
- trialShare
- 0.013134
- activeTrials
- 261
- burdenSourceId
- CI-SOURCE-00000011
- sumActiveTrials
- 19872
- eligibleEntities
- 35
- countersComputedAt
- 2026-09-29 02:00:20.557824-04
- mortalityObservationId
- 9070
- componentsFormulaVersion
- ci-research-gap-components-v1
ranking row 2580370 |